Listed

Annovis Bio, Inc.

ANVSNYSECIK 1477845HealthcareFiscal year ends Dec 31

Reports and events: 131 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Annovis Bio, Inc., Reports and events
FiledFormWhat it isAccession number
2024-07-1608:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-080039
2024-07-1016:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-078937
2024-07-0208:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-077093
2024-06-1306:05 ET8-K5.07 Shareholder vote results0001104659-24-071011
2024-06-1117:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-070450
2024-06-0516:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-068701
2024-05-2116:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-063829
2024-05-1316:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-24-060518
2024-05-1017:11 ET10-QQuarterly reportPeriod 2024-03-310001558370-24-007820
2024-05-0916:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-059315
2024-05-0617:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-057525
2024-05-0216:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-24-006534
2024-05-0117:18 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-24-055838
2024-04-2917:10 ETDEF 14AProxy statementPeriod 2024-06-120001104659-24-054167
2024-04-2608:14 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-24-052471
2024-04-0318:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-24-042695
2024-03-2917:12 ET10-KAnnual reportPeriod 2023-12-310001558370-24-004393
2024-03-2217:24 ET8-K8.01 Other events0001104659-24-037958
2024-03-2117:23 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-24-037406
2024-03-2016:43 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-036742
2024-03-2021:20 ET8-K8.01 Other events0001104659-24-036331
2024-03-1517:22 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-24-035082
2023-11-0816:45 ET10-QQuarterly reportPeriod 2023-09-300001558370-23-018298
2023-11-0112:28 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-113281
2023-10-3017:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-112633
2023-10-1319:39 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-108892
2023-08-1416:40 ET10-QQuarterly reportPeriod 2023-06-300001558370-23-014884
2023-06-1616:17 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-23-072250
2023-05-3017:20 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001104659-23-066171
2023-05-1016:34 ET10-QQuarterly reportPeriod 2023-03-310001558370-23-009142
2023-04-2808:00 ETDEF 14AProxy statementPeriod 2023-06-150001104659-23-052107
2023-04-0408:39 ET8-K1.02 Termination of a material agreement; 8.01 Other events0001104659-23-041237
2023-04-0317:28 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-23-041009
2023-04-0307:52 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-040537
2023-03-3116:58 ET10-KAnnual reportPeriod 2022-12-310001104659-23-040275
2023-03-3109:18 ET8-K7.01 Regulation FD disclosure0001104659-23-039748
2023-03-0617:02 ET8-K4.02 Non-reliance on financial statements0001104659-23-029078
2023-02-1314:59 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-019581
2023-01-0616:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-001850
2022-11-0816:44 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-016902
2022-09-1217:09 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-099298
2022-08-3006:01 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-095769
2022-08-0811:44 ET10-QQuarterly reportPeriod 2022-06-300001558370-22-012561
2022-08-0808:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-086948
2022-06-0308:54 ET8-K5.07 Shareholder vote results0001104659-22-067880
2022-05-0411:42 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-006981
2022-05-0408:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-055573
2022-04-1816:11 ETDEF 14AProxy statementPeriod 2022-06-020001104659-22-046860
2022-03-0216:12 ET10-KAnnual reportPeriod 2021-12-310001558370-22-002668
2021-11-1514:33 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-139005

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:17 ET. Listed shows no prices and gives no investment advice.